A new kind of rat model
...sin-Milwaukee (UWM) are working with local company physiogenix
to investigate a novel animal model the company ha... methods, says Steven Nye, director of genomics at physiogenix
and principal investigator of the National Institu...ciety for Neuroscience in November.
plans to distribute the consomic rats to academic ...
Tech Digest: Nanotechnology, GE Healthcare, NovaMed, PhysioGenix
UW-Madison nanotechnology exhibit to open Thursday
Madison, Wis. The UW-Madison Engineering Centers Building will hold an exhibit on advances in nanotechnology, run by the university and Milwaukees Discovery World Museum . It opens at 4:30 p.m. on December 16 during a campus open house, wi...
On site at BIO 2003
...on-based biotech companies including EraGen Bioscience, Gala Design, and Scientific Protein Labs. Milwaukee companies that participated were Prodesse, physiogenix
and PointOne who shared an exhibit space with Milwaukee Economic Development Corporation and Techstar. The Marshfield Clinic, Medical College of Wisco...
Milwaukee research institutions step up the pace for technology transfer
...tart to see more entrepreneurial activity coming out of other institutions beyond Madison. Start-up companies with ties to MCW are PointOne, Prodesse, physiogenix
On the same day Doyle announced the Tech Star grant, he also singled out NovaScan, a Milwaukee firm that is the first to receive ...
Five remaining firms vie for Tech Transfer award
...ent for fruits that accelerates uniform ripening and extend shelf life
, Wauwatosa, a Medical College of Wisconsin spinoff that specializes in pre...ohnson & Johnson because he was excited about the drug development process. physiogenix
believes it can arm drug developers with more effective drug screening tool...
Wisconsin to show up at BIO in numbers
John Seman, CEO of PhysioGenix, said his company's driving interest is to network and identify new customers interested in its products and services. physiogenix
provides contract research services that focus on the safety and effectiveness of new drugs before they enter human clinical trials.